Skip to content

Author

A. O. Saleh

We have 5 of 25 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta‐Analysis of Randomized Clinical Trials

This network meta‐analysis addresses the limited dose‐specific comparative evidence by evaluating different doses of tirzepatide (TZP) versus dulaglutide (DULA) for glycemic control, weight loss, and safety in type 2 diabetes mellitus (T2DM).

A. Hageen, A. Gadelmawla, A. O. Saleh et al. · 0 citations
Meta-analysis Open access Sep 2026

Autologous bone grafts versus alloplastic implants for orbital floor reconstruction: a systematic review and meta-analysis

Alloplastic biomaterials represent a safe and effective alternative for orbital floor reconstruction; however, the predominance of retrospective, heterogeneous studies in the current evidence base means these findings should inform, rather than replace, individualized surgical decision-making pending further high-quali...

Mohammed Ehmidat, A. S. Gad, A. O. Saleh et al. · 0 citations
Review Open access Sep 2026

Clinicopathological differences and risk factors of early- versus late-onset pancreatic cancer: A systematic review and meta-analysis

Overall, EOPC demonstrated a distinct clinicopathological phenotype characterized by more aggressive pathological features and advanced nodal disease, emphasizing the need for age-specific pancreatic cancer management.

M. Alzoubi, Rahaf Al Jibarat, A. O. Saleh et al. · 0 citations
Review Open access Sep 2026

Clinicopathological differences and risk factors of early- versus late-onset pancreatic cancer: A systematic review and meta-analysis.

Pancreatic cancer is one of the most aggressive malignancies worldwide, and the incidence is increasing in patients under the age of 50. We systematically reviewed the clinicopathological features of early-onset pancreatic cancer (EOPC) and late-onset pancreatic cancer (LOPC) to help develop tailored therapeutic strate...

M. Alzoubi, Rahaf Al Jibarat, A. O. Saleh et al. · 0 citations
Review Aug 2026

Remimazolam vs midazolam for sedation in upper gastrointestinal endoscopy: a systematic review and meta-analysis.

In conclusion, remimazolam may represent a safe and effective alternative to midazolam for upper gastrointestinal endoscopy, with faster cognitive recovery, as reflected by shorter time to full alertness and earlier discharge.

Salma Bahnasy, A. O. Saleh, Ibrahim A. Ababneh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.